Welcure Drugs & Pharmaceuticals Limited

WELCURE6

INE331C01017

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 12:15:00 03/06/2024 pm IST			5-day change	1st Jan Change
4.52 ^INR	-4.84%		-11.55%	+17.40%

22/03	Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	CI
16/02	Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	MT

Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023

July 11, 2023 at 06:53 pm IST

Welcure Drugs & Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported revenue was INR 2.21 million compared to INR 0.825 million a year ago. Net income was INR 1.67 million compared to INR 0.67 million a year ago.

Latest news about Welcure Drugs & Pharmaceuticals Limited

Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	22/03	CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	16/02	MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	15/02	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	14/02	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	14/11	CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	14/11	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	30/23/30	CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	30/23/30	CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	04/23/04	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11/23/11	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	08/22/08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	08/22/08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022	08/22/08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022	08/22/08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change in Registered Office Address	08/22/08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Chief Financial Officer Changes	01/22/01	CI
Welcure Drugs & Pharmaceuticals Limited Announces Appointment of Directors	01/22/01	CI

Chart Welcure Drugs & Pharmaceuticals Limited

Duration

Period

Chart Welcure Drugs & Pharmaceuticals Limited

More charts

Company Profile

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.

Sector

Pharmaceuticals

Calendar

08/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
WELCURE DRUGS & PHARMACEUTICALS LIMITED	+17.40%	769K
CARDINAL HEALTH, INC.	-1.52%	24.18B
SINOPHARM GROUP CO. LTD.	+3.91%	8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	8.34B
HUADONG MEDICINE CO., LTD	-23.71%	7.64B
H. LUNDBECK A/S	+15.20%	5.33B
GALENICA AG	+2.68%	4.12B
EBOS GROUP LIMITED	-6.90%	3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+18.80%	3.54B